Detailed Notes on HSK16149
Participant has had any other prior or concurrent malignancy in just two many years previous to enrollment with the next exceptions: adequately dealt with localized basal cell or squamous mobile carcinoma, or curatively addressed in situ carcinoma of your cervix or breast. Other exceptions could be regarded on sponsor consultation.For Component 2A,